Investing.com - TD Cowen raised its price target on Krystal Biotech (NASDAQ:KRYS) to $306.00 from $202.00 on Friday, while maintaining a Buy rating on the stock. The new target represents potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results